{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:51:13Z","timestamp":1763279473080,"version":"3.45.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,15]]},"DOI":"10.7759\/cureus.96937","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:48:45Z","timestamp":1763279325000},"source":"Crossref","is-referenced-by-count":0,"title":["Side Effects of COVID-19 Vaccination Among Medical Students in Bangladesh: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Abu Saleh Md Sadequl","family":"Islam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjida","family":"Sanjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed U","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadman","family":"Saify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustari Sarkar","family":"Trisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmudul Hasan","family":"Nahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO COVID-19 dashboard. (2024). https.\/\/covid19.who.int\/."},{"key":"ref2","unstructured":"Institute of Epidemiology, Disease Control and Research (IEDCR). COVID-19 status - Bangladesh. (2024). https.\/\/www.iedcr.org\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood B","year":"2014","unstructured":"Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014, 369:20130433. 10.1098\/rstb.2013.0433","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer F","year":"2020","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020, 586:516-27. 10.1038\/s41586-020-2798-3","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack FP","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al.. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020, 383:2603-15. 10.1056\/NEJMoa2034577","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Clemens SA, Madhi SA, et al.. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021, 397:99-111. 10.1016\/S0140-6736(20)32661-1","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden LR","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al.. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021, 384:403-16. 10.1056\/NEJMoa2035389","journal-title":"N Engl J Med"},{"key":"ref8","unstructured":"Directorate General of Health Services (DGHS). National COVID-19 Vaccination Program, Bangladesh. (2021). https.\/\/old.dghs.gov.bd\/index.php\/en\/component\/content\/article?id=5393."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020160","article-title":"COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates","volume":"9","author":"Sallam M","year":"2021","unstructured":"Sallam M.  COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021, 9:160. 10.3390\/vaccines9020160","journal-title":"Vaccines (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi6488","article-title":"Volatility of vaccine confidence","volume":"371","author":"Larson HJ","year":"2021","unstructured":"Larson HJ, Broniatowski DA. Volatility of vaccine confidence. Science. 2021, 371:1289. 10.1126\/science.abi6488","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100207","article-title":"Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: a cross-sectional study","volume":"12","author":"Mohsin M","year":"2022","unstructured":"Mohsin M, Mahmud S, Uddin Mian A, et al.. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: a cross-sectional study. Vaccine X. 2022, 12:100207. 10.1016\/j.jvacx.2022.100207","journal-title":"Vaccine X"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1361374","article-title":"Experience and side effects of COVID-19 vaccine uptake among university students: a cross-sectional survey study","volume":"12","author":"Islam MA","year":"2024","unstructured":"Islam MA, Nahar MT, Rahman A, et al.. Experience and side effects of COVID-19 vaccine uptake among university students: a cross-sectional survey study. Front Public Health. 2024, 12:1361374. 10.3389\/fpubh.2024.1361374","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.06.036","article-title":"The loneliness pandemic: loneliness and other concomitants of depression, anxiety and their comorbidity during the COVID-19 outbreak","volume":"275","author":"Palgi Y","year":"2020","unstructured":"Palgi Y, Shrira A, Ring L, et al.. The loneliness pandemic: loneliness and other concomitants of depression, anxiety and their comorbidity during the COVID-19 outbreak. J Affect Disord. 2020, 275:109-11. 10.1016\/j.jad.2020.06.036","journal-title":"J Affect Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2022.02.002","article-title":"Association between alopecia areata and COVID-19: a systematic review","volume":"7","author":"Christensen RE","year":"2022","unstructured":"Christensen RE, Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int. 2022, 7:57-61. 10.1016\/j.jdin.2022.02.002","journal-title":"JAAD Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15313","article-title":"Telogen effluvium: a sequela of COVID-19","volume":"60","author":"Mieczkowska K","year":"2021","unstructured":"Mieczkowska K, Deutsch A, Borok J, et al.. Telogen effluvium: a sequela of COVID-19. Int J Dermatol. 2021, 60:122-4. 10.1111\/ijd.15313","journal-title":"Int J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni C","year":"2021","unstructured":"Menni C, Klaser K, May A, et al.. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021, 21:939-49. 10.1016\/S1473-3099(21)00224-3","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine \u2014 United States, August 12-September 19, 2021","volume":"70","author":"Hause AM","year":"2021","unstructured":"Hause AM, Baggs J, Gee J, Marquez P, Myers TR, Shimabukuro TT, Shay DK. Safety monitoring of an additional dose of COVID-19 vaccine \u2014 United States, August 12-September 19, 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:1379-84. 10.15585\/mmwr.mm7039e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7107e1","article-title":"Safety monitoring of COVID-19 vaccine booster doses among adults \u2014 United States, September 22, 2021-February 6, 2022","volume":"71","author":"Hause AM","year":"2022","unstructured":"Hause AM, Baggs J, Marquez P, et al.. Safety monitoring of COVID-19 vaccine booster doses among adults \u2014 United States, September 22, 2021-February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:249-54. 10.15585\/mmwr.mm7107e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine","volume":"386","author":"Moreira ED Jr","year":"2022","unstructured":"Moreira ED Jr, Kitchin N, Xu X, et al.. Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine. N Engl J Med. 2022, 386:1910-21. 10.1056\/NEJMoa2200674","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro AP","year":"2021","unstructured":"Munro AP, Janani L, Cornelius V, et al.. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021, 398:2258-76. 10.1016\/S0140-6736(21)02717-3","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia S","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, et al.. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021, 21:39-51. 10.1016\/S1473-3099(20)30831-8","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial","volume":"326","author":"Al Kaabi N","year":"2021","unstructured":"Al Kaabi N, Zhang Y, Xia S, et al.. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA. 2021, 326:35-45. 10.1001\/jama.2021.8565","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad A","year":"2021","unstructured":"Riad A, Pokorn\u00e1 A, Attia S, Klugarov\u00e1 J, Ko\u0161\u010d\u00edk M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021, 10:1428. 10.3390\/jcm10071428","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia","volume":"9","author":"Alhazmi A","year":"2021","unstructured":"Alhazmi A, Alamer E, Daws D, et al.. Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines (Basel). 2021, 9:674. 10.3390\/vaccines9060674","journal-title":"Vaccines (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty AL","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, et al.. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021, 4:e2140364. 10.1001\/jamanetworkopen.2021.40364","journal-title":"JAMA Netw Open"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein SL","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016, 16:626-38. 10.1038\/nri.2016.90","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00035.2015","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink AL","year":"2015","unstructured":"Fink AL, Klein SL. Sex and gender impact immune responses to vaccines among the elderly. Physiology (Bethesda). 2015, 30:408-16. 10.1152\/physiol.00035.2015","journal-title":"Physiology (Bethesda)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-024-00625-z","article-title":"Sex and gender differences in adverse events following influenza and COVID-19 vaccination","volume":"15","author":"Yin A","year":"2024","unstructured":"Yin A, Wang N, Shea PJ, et al.. Sex and gender differences in adverse events following influenza and COVID-19 vaccination. Biol Sex Differ. 2024, 15:50. 10.1186\/s13293-024-00625-z","journal-title":"Biol Sex Differ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination","volume":"111","author":"Saeed BQ","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021, 111:219-26. 10.1016\/j.ijid.2021.08.013","journal-title":"Int J Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02059-5","article-title":"Evaluation of the safety profile of COVID-19 vaccines: a rapid review","volume":"19","author":"Wu Q","year":"2021","unstructured":"Wu Q, Dudley MZ, Chen X, et al.. Evaluation of the safety profile of COVID-19 vaccines: a rapid review. BMC Med. 2021, 19:173. 10.1186\/s12916-021-02059-5","journal-title":"BMC Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090989","article-title":"Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3","volume":"9","author":"Fan YJ","year":"2021","unstructured":"Fan YJ, Chan KH, Hung IF. Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3. Vaccines (Basel). 2021, 9:989. 10.3390\/vaccines9090989","journal-title":"Vaccines (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal J","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, et al.. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021, 385:585-94. 10.1056\/NEJMoa2108891","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent Omicron-containing booster vaccine against COVID-19","volume":"387","author":"Chalkias S","year":"2022","unstructured":"Chalkias S, Harper C, Vrbicky K, et al.. A bivalent Omicron-containing booster vaccine against COVID-19. N Engl J Med. 2022, 387:1279-91. 10.1056\/NEJMoa2208343","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nedt.2021.105010","article-title":"Factors influencing nursing students' intention to accept COVID-19 vaccination: a pooled analysis of seven European countries","volume":"104","author":"Patelarou E","year":"2021","unstructured":"Patelarou E, Galanis P, Mechili EA, et al.. Factors influencing nursing students' intention to accept COVID-19 vaccination: a pooled analysis of seven European countries. Nurse Educ Today. 2021, 104:105010. 10.1016\/j.nedt.2021.105010","journal-title":"Nurse Educ Today"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali RA","year":"2021","unstructured":"Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021, 106:376-81. 10.1016\/j.ijid.2021.04.047","journal-title":"Int J Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdaa230","article-title":"COVID-19 vaccine hesitancy among medical students","volume":"43","author":"Lucia VC","year":"2021","unstructured":"Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2021, 43:445-9. 10.1093\/pubmed\/fdaa230","journal-title":"J Public Health (Oxf)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19074072","article-title":"Prevalence of COVID-19 vaccination among medical students: a systematic review and meta-analysis","volume":"19","author":"Ulbrichtova R","year":"2022","unstructured":"Ulbrichtova R, Svihrova V, Svihra J. Prevalence of COVID-19 vaccination among medical students: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022, 19:4072. 10.3390\/ijerph19074072","journal-title":"Int J Environ Res Public Health"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3329\/bsmmcj.v3i1.71916","article-title":"Monitoring Oxford-AstraZeneca COVID-19 vaccine side effects in Faridpur, Bangladesh: a prospective study","volume":"3","author":"Arif KM","year":"2024","unstructured":"Arif KM, Biswas R, Islam MMSU, Rahman AA. Monitoring Oxford-AstraZeneca COVID-19 vaccine side effects in Faridpur, Bangladesh: a prospective study. Bangabandhu Sheikh Mujib Medical Coll J. 2024, 3:16-21. 10.3329\/bsmmcj.v3i1.71916","journal-title":"Bangabandhu Sheikh Mujib Medical Coll J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring \u2014 United States, December 14, 2020-January 13, 2021","volume":"70","author":"Gee J","year":"2021","unstructured":"Gee J, Marquez P, Su J, et al.. First month of COVID-19 vaccine safety monitoring \u2014 United States, December 14, 2020-January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:283-8. 10.15585\/mmwr.mm7008e3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26910","article-title":"Vaccine hesitancy: beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students","volume":"93","author":"Saied SM","year":"2021","unstructured":"Saied SM, Saied EM, Kabbash IA, Abdo SA. Vaccine hesitancy: beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021, 93:4280-91. 10.1002\/jmv.26910","journal-title":"J Med Virol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S310497","article-title":"Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study","volume":"14","author":"El-Shitany NA","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, et al.. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021, 14:1389-401. 10.2147\/IJGM.S310497","journal-title":"Int J Gen Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/430106-side-effects-of-covid-19-vaccination-among-medical-students-in-bangladesh-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T07:48:46Z","timestamp":1763279326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/430106-side-effects-of-covid-19-vaccination-among-medical-students-in-bangladesh-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.96937","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,15]]}}}